Anti-CD8 [14]
Invented by Prof Nancy Hogg from Cancer Research UK London Research Institute: Lincoln's Inn Fields
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 151035 |
Applications | ELISA FACS IHC IP |
Antigen/Gene or Protein Targets | CD8 |
Synonyms | Leu2 |
Reactivity | Human |
Relevance | CD8 is a T cell co-receptor that recognises, together with the T cell receptor, MHC class I molecules. CD8 is present on human suppressor / cytotoxic T cells, 30% of circulating T cells. Clone 14 is recommended for: the detection of immunoregulatory T cell subset imbalances in autoimmune disorders and immunodeficiency states, categorisation of T cell acute lymphoblastic leukaemia and lymphoblastic lymphoma in conjunction with other antigens and determination of CD4/CD8 ratios in immune deficiencies, rheumatoid arthritis and multiple sclerosis. |
Host | Mouse |
Immunogen | Fibronectin-purified human monocytes |
Subclass | IgG1 |
Recommended Growing Conditions | DMEM + 5% FCS |
Notes |
Recommended for T-cell enrichment by cell sorting or panning. Suitability for western blotting not known; to be confirmed - therefore WB not listed as a definite application. |
Research Area | Cancer, Immunology, Stem Cell Biology |
References: 2 entries
Hogg et al. 1999. J Clin Invest. 103(1):97-106. PMID: 9884339.
A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.
Europe PMC ID: 9884339
Add a reference
References: 2 entries
Hogg et al. 1999. J Clin Invest. 103(1):97-106. PMID: 9884339.
A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.
Add a reference